# levocetirizine dihydrochloride

NDC: 51655-564
Generic name: levocetirizine dihydrochloride
Labeler / Manufacturer: Northwind Health Company, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20210125

FDA application: ANDA203646

## Active ingredients

- LEVOCETIRIZINE DIHYDROCHLORIDE: 5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51655-564"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51655-564
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dae403cd-b6fc-7c50-e053-2995a90a95e3